ELAB Elevai Labs Inc. Quick Ratio

Elevai Labs Inc. (ELAB) is a pioneer in biocosmetics, utilizing stem cell exosomes for tissue repair and rejuvenation. The company's revenue is driven by premium aesthetic medicine products sold through D2C services, spa centers, and dermatology. Currently, Elevai Labs Inc. (ELAB) is organically expanding its B2B sales without relying on mergers, and the price chart with the 1.25 coefficient reflects the current stock dynamics following its public listing.

Investors utilize liquidity multiples to verify an issuer's ability to promptly settle short-term obligations. The acid-test trend reflects the solvency of Elevai Labs Inc. (ELAB), accounting only for cash and accounts receivable while excluding inventory. This is a critical metric for the company, as premium marketing expenses and cosmeceutical regulatory risks exert pressure on limited cash reserves. Low indicator values signal a risk of a liquidity gap.